SIETES :: 93213 citas

Resultados de la búsqueda por EI REFINAR BÚSQUEDA

1.

Castells MC, Phillips EJ. Maintaining safety with SARS-CoV-2 vaccines. N Engl J Med 2020;383:30 de diciembre. [Ref.ID 103836]

2.

Aby ES, Rodin H, Debes JD. Proton pump inhibitors and mortality in individuals with COVID-19. The American Journal of Gastroenterology 2020;115:octubre. [Ref.ID 103830]

3.

Anónimo. COVID-19 vaccines and severe allergic reactions. Centers for Disease Control and Prevention 2020:19 de diciembre. [Ref.ID 103829]

4.

Axelrod T. FDA investigating allergic reactions to Pfizer vaccine reported in multiple states. The Hill 2020:19 de diciembre. [Ref.ID 103828]

5.

Parsons L. Moderna scores FDA panel backing for mRNA-based COVID-19 vaccine. PMLiVE 2020:18 de diciembre. [Ref.ID 103823]

6.

Herper M. FDA scientists endorse Moderna Covid-19 vaccine, as documents provide new hints on efficacy. STAT 2020:1. [Ref.ID 103819]

7.

Weigand AJ, Bondi.MW, Thomas KR, Campbell NL, et al.. Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults. Neurology 2020;95:e2295-304. [Ref.ID 103815]

8.

Rubin EJ, Longo DL. SARS-CoV-2 vaccination — An ounce (actually, much less) of prevention. N Engl J Med 2020;383:31 de diciembre. [Ref.ID 103812]

9.

Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini CC, Bailey R, Swanson KA, et al. for the C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med 2020;383:10 de diciembre. [Ref.ID 103811]

10.

Tena B. UK recomienda que las personas alérgicas no se vacunen al registrar dos casos de reacciones. El Confidencial 2020:4. [Ref.ID 103810]

11.

Zhou J, Wang X, Lee S, Wu WKK, Cheung BMY, Zhang Q, Tse G. Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study. Gut 2020:diciembre. [Ref.ID 103806]

12.

Hetland ML, Haavardsholm EA, Rudin A, Nordtröm D, Nurmohamed M, Gudbjornsson B, Lampa J, et al.. Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial. BMJ 2020;371:2 de diciembre. [Ref.ID 103805]

13.

Hababi S, Heinrich A, Omer SB. No-fault compensation for vaccine injury — The other side of equitable access to covid-19 vaccines. N Engl J Med 2020;383:3 de diciembre. [Ref.ID 103803]

14.

Doshi P. Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data. BMJ 2020:26 de noviembre. [Ref.ID 103797]

15.

Almario CV, Chey WD, Spiegel BMR. Increased risk of COVID-19 among users of proton-pump inhibitors. The American Journal of Gastroenterology 2020;115:octubre. [Ref.ID 103795]

16.

Zhang X-Y, Wu H-B, Ling Y, Qian Z-P, Chen L. Analysis of the effect of proton pump inhibitors on the course of common COVID-19. medRxiv 2020:13 de junio. [Ref.ID 103794]

17.

Jimenez L, Campos Codo A, de Souza Sampaio V, Oliveira AER, Kobo Ferreira LK, Gastao Davanzo G, et al.. The influence of pH on SARS-CoV-2 infection and COVID-19 severity. medRxiv 2020:. [Ref.ID 103792]

18.

Vila-Corcoles A, Satue-Gracia E, Ochoa-Gondar O, Torrente-Fraga C, Gomez-Bertomeu F, Vila-Rovira A, Hospital-Guardiola I, de Diego-Cabanes C, Bejarano-Romero F, Rovira-Veciana D, Basora-Gallisa J. Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: A population-based cohort study in Southern Catalonia, Spain. The Journal of Clinical Hypertension 2020;22:agosto. [Ref.ID 103791]

19.

Li G-F, An X-X, Yu Y, Jiao L-R, Canarutto D, Yu G, Wang G, Wu D-N, Xiao Y. Do proton pump inhibitors influence SARS-CoV- 2 related outcomes? A meta-analysis. Gut 2020:10 de noviembre. [Ref.ID 103790]

20.

Hägg S, Jönsson AK, Ahlner J. Current evidence on abuse and misuse of gabapentinoids. Drug Saf 2020;43:1235-54. [Ref.ID 103789]